Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over
the past several decades. In this review the factors that have been linked to this …

Linezolid is an oxazolidinone antibiotic in clinical use for the treatment of serious infections
of resistant Gram-positive bacteria. It inhibits protein synthesis by binding to the peptidyl …

There is a dire need for infection prevention strategies that do not require the use of
antibiotics, which exacerbate the rise of multi-and pan-drug resistant infectious organisms …

The success of linezolid stimulated significant efforts to discover new agents in the
oxazolidinone class. Over a dozen oxazolidinones have reached the clinic, but many were …

Biofouling accumulates living organisms on surfaces in contact with the water and causes
significant economic, structural, and microbial problems on ship hulls, piers, oil rigs, power …

The epidemiology of Staphylococcus epidermidis in US hospitals remains limited. This study
aimed to address the genetic backgrounds of linezolid-susceptible and-resistant S …

Objectives This study was a detailed investigation of Staphylococcus epidermidis clinical
isolates exhibiting linezolid resistance. Methods Thirty-six linezolid-resistant S. epidermidis …

Linezolid, the first oxazolidinone to be used clinically, is effective in the treatment of
infections caused by various Gram-positive pathogens, including multidrug resistant …

Coagulase-negative staphylococci, ubiquitous commensals of human skin, and mucous
membranes represent important pathogens for immunocompromised patients and neonates …

Methicillin‐resistant S taphylococcus aureus (MRSA) is an important cause of antimicrobial‐
resistant hospital‐acquired infections worldwide and remains a public health priority in …